Clinical Trial

Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the safety and effects of atorvastatin in treatment of Chinese Kawasaki disease (KD) children complicated with coronary artery abnormalities (CAA) in acute phase. The main questions it aims to answer are: Is atorvastatin safe in Chinese children of acute KD? Does atorvastatin contribute to control the acute inflammation in KD and improve the CAA?
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-17
critical Phase changed: not specified -> Phase 3 2026-06-17
minor Trial arms changed: 0 -> 4 2026-06-17
Trial Details
NCT Number NCT07530640
Lead Sponsor Children's Hospital of Fudan University
Conditions Kawasaki Disease, Coronary Artery Abnormalities
Enrollment 9 participants
Start Date 2026-06-08
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-16